Circulating microRNA Profiles Identify a Patient Subgroup with High Inflammation and Severe Symptoms in Schizophrenia Experiencing Acute Psychosis

T Miyano, T Mikkaichi, K Nakamura… - International Journal of …, 2024 - mdpi.com
Schizophrenia is a complex and heterogenous psychiatric disorder. This study aimed to
demonstrate the potential of circulating microRNAs (miRNAs) as a clinical biomarker to …
被引用次数：2 相关文章

Circulating microRNA Profiles Identify a Patient Subgroup with High Inflammation and Severe Symptoms in Schizophrenia Experiencing Acute Psychosis.

T Miyano, T Mikkaichi, K Nakamura… - International …, 2024 - search.ebscohost.com
Schizophrenia is a complex and heterogenous psychiatric disorder. This study aimed to
demonstrate the potential of circulating microRNAs (miRNAs) as a clinical biomarker to …

Circulating microRNA Profiles Identify a Patient Subgroup with High Inflammation and Severe Symptoms in Schizophrenia Experiencing Acute Psychosis

T Miyano, T Mikkaichi, K Nakamura… - International …, 2024 - pubmed.ncbi.nlm.nih.gov
Schizophrenia is a complex and heterogenous psychiatric disorder. This study aimed to
demonstrate the potential of circulating microRNAs (miRNAs) as a clinical biomarker to …

Circulating microRNA Profiles Identify a Patient Subgroup with High Inflammation and Severe Symptoms in Schizophrenia Experiencing Acute Psychosis.

T Miyano, T Mikkaichi, K Nakamura… - … Journal of Molecular …, 2024 - europepmc.org
Schizophrenia is a complex and heterogenous psychiatric disorder. This study aimed to
demonstrate the potential of circulating microRNAs (miRNAs) as a clinical biomarker to …
[HTML] nih.gov

[HTML][HTML] Circulating microRNA Profiles Identify a Patient Subgroup with High Inflammation and Severe Symptoms in Schizophrenia Experiencing Acute Psychosis

T Miyano, T Mikkaichi, K Nakamura… - … Journal of Molecular …, 2024 - ncbi.nlm.nih.gov
Schizophrenia is a complex and heterogenous psychiatric disorder. This study aimed to
demonstrate the potential of circulating microRNAs (miRNAs) as a clinical biomarker to …